Pharmacodynamics of B-Cell Depletion and Pharmacokinetics of the Novel Anti-CD20 Monoclonal Antibody Ublituximab in Patients With Relapsing Multiple Sclerosis

被引：0

作者：

Fox, E. ^{[1
]}

Steinman, L. ^{[2
]}

Hartung, H. ^{[3
,4
,5
,6
]}

Alvarez, E. ^{[7
]}

Qian, P. ^{[8
]}

Wray, S. ^{[9
]}

Robertson, D. ^{[10
]}

Huang, D. ^{[11
]}

Selmaj, K. ^{[12
]}

Wynn, D. ^{[13
]}

Weiss, M. S. ^{[14
]}

Bosco, J. A. ^{[14
]}

Power, S. A. ^{[14
]}

Mok, K. A. ^{[14
]}

Lee, L. ^{[14
]}

Cree, B. A. ^{[15
]}

机构：

[1] Cent Texas Neurol Consultants, Round Rock, TX USA

[2] Stanford Univ, Stanford, CA 94305 USA

[3] Heinrich Heine Univ, Dusseldorf, Germany

[4] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia

[5] Med Univ Vienna, Vienna, Austria

[6] Palacky Univ, Olomouc, Czech Republic

[7] Univ Colorado, Aurora, CO USA

[8] Swedish Med Ctr, Seattle, WA USA

[9] Hope Neurol, Knoxville, TN USA

[10] Univ S Florida, Tampa, FL 33620 USA

[11] Mt Carmel Hlth Syst, Ctr Multiple Sclerosis, Westerville, OH USA

[12] Univ Warmia & Mazury, Ctr Neurol, Lodz, Poland

[13] Consultants Neurol, Northbrook, IL USA

[14] TG Therapeut Inc, New York, NY USA

[15] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P105

引用

页码：68 / 68

页数：1